Abstract:Aquaculture, the fastest growing food-producing sector, now accounts for nearly 50 % of the world’s food fish (FAO in The state of world fisheries and aquaculture. FAO, Rome, 2010). The global aquaculture production of food fish reached 62.7 million tonnes in 2011 and is continuously increasing with an estimated production of food fish of 66.5 million tonnes in 2012 (a 9.4 % increase in 1 year, FAO, www.fao.org/fishery/topic/16140). Aquaculture is not only important for sustainable protein-based food fish production but also for the aquaculture industry and economy worldwide. Disease prevention is the key issue to maintain a sustainable development of aquaculture. Widespread use of antibiotics in aquaculture has led to the development of antibiotic-resistant bacteria and the accumulation of antibiotics in the environment, resulting in water and soil pollution. Thus, vaccination is the most effective and environmentally-friendly approach to combat diseases in aquaculture to manage fish health. Furthermore, when compared to >760 vaccines against human diseases, there are only about 30 fish vaccines commercially available, suggesting the urgent need for development and cost-effective production of fish vaccines for managing fish health, especially in the fast growing fish farming in Asia where profit is minimal and therefore given high priority. Plant genetic engineering has made significant contributions to production of biotech crops for food, feed, valuable recombinant proteins etc. in the past three decades. The use of plants for vaccine production offers several advantages such as low cost, safety and easy scaling up. To date a large number of plant-derived vaccines, antibodies and therapeutic proteins have been produced for human health, of which a few have been made commercially available. However, the development of animal vaccines in plants, especially fish vaccines by genetic engineering, has not yet been addressed. Therefore, there is a need to exploit plant biotechnology for cost effective fish vaccine development in plants, in particular, edible crops for oral fish vaccines. This review provides insight into (1) the current status of fish vaccine and vaccination in aquaculture, (2) plant biotechnology and edible crops for fish vaccines for oral administration, (3) regulatory constraints and (4) conclusions and future perspectives.

Recent Development and Future Prospects of Plant-Based Vaccines

Recent Progress and Challenges in the Development of Edible Vaccines Produced by Genetically Modified Plants

Edible Vaccines: A Patent-Driven Exploration of Immunization Technologies

Edible Vaccines: Promises and Challenges

Plants That Can be Used as Plant-Based Edible Vaccines; Current Situation and Recent Developments

EDIBLE PLANT-BASED VACCINES:PROGRESS IN ANIMAL TESTS AND CLINICAL TRAILS

Plant-Derived Human Vaccines: Recent Developments

Edible vaccines against veterinary parasitic diseases--current status and future prospects

Recent Advances and Safety Issues of Transgenic Plant-Derived Vaccines.

Plant-made vaccine antigens and biopharmaceuticals

A cross talk between the immunization and edible vaccine: Current challenges and future prospects

Research Advances on Transgenic Plant Vaccines

Plant‐Made Vaccines Targeting Enteric Pathogens—Safe Alternatives for Vaccination in Developing Countries

Review About Plant-induced Edible Vaccine and Its Safety Research

Research advances on transgenic plant vaccines.

The New Progress of the Research and Application of Edible Vaccines

Recent advances in expression and purification strategies for plant made vaccines

Recent Developments in Therapeutic Protein Expression Technologies in Plants

Plant-based solutions for veterinary immunotherapeutics and prophylactics

Progress on edible vaccing

How can plant genetic engineering contribute to cost-effective fish vaccine development for promoting sustainable aquaculture?